Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)

China flag China · Delayed Price · Currency is CNY
19.36
+0.05 (0.26%)
At close: Jan 23, 2026
9.56%
Market Cap4.25B
Revenue (ttm)351.25M
Net Income (ttm)7.10M
Shares Out219.47M
EPS (ttm)0.03
PE Ratio598.70
Forward PEn/a
Dividend1.20 (6.20%)
Ex-Dividend DateJun 12, 2025
Volume2,972,275
Average Volume4,228,302
Open19.31
Previous Close19.31
Day's Range19.21 - 19.36
52-Week Range16.10 - 23.28
Beta0.41
RSI64.78
Earnings DateApr 24, 2026

About SHE:002932

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents and diagnostic instruments in China. The company offers external diagnostic testing, third-party medical testing, certification consulting services, and medical information platform construction services. It also provides information software and supporting hardware products. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. was founded in 2008 and is based in Wuhan, China. [Read more]

Sector Healthcare
Founded 2008
Employees 812
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002932
Full Company Profile

Financial Performance

In 2024, SHE:002932's revenue was 350.06 million, a decrease of -53.30% compared to the previous year's 749.54 million. Earnings were 74.52 million, a decrease of -0.54%.

Financial Statements